<DOC>
	<DOCNO>NCT02853188</DOCNO>
	<brief_summary>The aim study evaluate plasma activity tissue factor time diagnosis lung cancer , treatment , treatment induction ( surgery two first cure chemotherapy ) , predictive factor venous thromboembolism disease year follow diagnosis , independently parameter .</brief_summary>
	<brief_title>Measure Plasma Tissue Factor Predict Venous Thromboembolism Primitive Cancer Lung</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Thromboplastin</mesh_term>
	<criteria>Patients 18 year old Patients cancer lung diagnosis carry less 2 month handle yet , either surgery chemotherapy , radiotherapy Patients whose life expectancy consider 3monthold superior Patients give writed consent Patients affiliate national insurance scheme benefit diet Patients receive treatment ( process ) anticoagulating preventive dose treatment stop least 3 day 1st take patient receive anticoagulating treatment ( case curative treatment , latter arrest least 3 month Patients hepatic disease coagulation disorder Patients anticoagulant dose guardian 3 month precede study present active infection Patients history cancer consider cure diagnosed less 5 year ( exception patient operate situ carcinoma neck womb patient undergone excision squamouscell carcinoma )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>